| Fiscal period | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Period End Date | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 |
|---|
| Product revenue | 147.79 | 130.46 | 114.61 | 105.53 | 107.78 | 102.93 | 87.70 | 75.47 | 71.77 | 68.01 |
| Licensing, milestone and contract revenue | -- | -- | -- | 0.02 | 5.64 | 0.45 | 5.30 | 30.12 | 3.31 | 3.35 |
| Total Revenues | 147.79 | 130.46 | 114.61 | 105.56 | 113.42 | 103.38 | 93.00 | 105.60 | 75.08 | 71.36 |
| Cost of product revenue | 64.85 | 61.43 | 28.75 | 31.28 | 27.36 | 24.03 | 21.05 | 20.93 | 22.77 | 28.99 |
| Gross Profit | 82.94 | 69.03 | 85.86 | 74.28 | -- | -- | -- | -- | -- | -- |
| Goodwill impairment | -- | 42.52 | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | 27.33 | 23.43 | 16.67 | 18.19 | 18.79 | 10.73 | 8.99 | 8.14 | 7.06 | 5.39 |
| Selling, general & administrative | 74.10 | 60.06 | 34.95 | 34.34 | 21.54 | 18.01 | 14.83 | 15.07 | 12.94 | 14.73 |
| Restructuring charges | -- | -- | -- | -- | -- | -- | -- | -- | (0.29) | 2.54 |
| Acquisition-related expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Litigation settlement costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in fair value of contingent consideration | 21.10 | 28.67 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.33 | 97.35 | 51.62 | 52.53 | 67.69 | 52.77 | 44.87 | 44.15 | 42.47 | 51.64 |
| Operating Income (Loss) | 2.62 | (28.32) | 34.25 | 21.75 | 45.73 | 50.61 | 48.13 | 61.45 | 32.61 | 19.72 |
| Gain on sale of securities | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income, net | (0.19) | (0.30) | 1.87 | 1.46 | 0.47 | 0.26 | 0.12 | 0.06 | (0.13) | (0.19) |
| Income (loss) before income taxes | 2.43 | (28.62) | 36.12 | 23.21 | 46.20 | 50.87 | 48.25 | 61.51 | 32.48 | 19.53 |
| Current: Federal | 0.49 | 0.36 | 6.25 | 4.78 | 12.61 | 14.98 | 14.57 | 18.30 | 8.02 | 7.59 |
| Current: State | (0.64) | (1.97) | 1.88 | 1.64 | 2.74 | 3.27 | 3.64 | 3.90 | 1.58 | 0.89 |
| Provision for income taxes | (1.71) | (4.64) | 8.93 | 4.49 | 14.39 | 18.32 | 17.50 | 23.19 | 11.91 | 7.77 |
| Deferred: Federal | (0.55) | (1.98) | 1.09 | (0.99) | (0.43) | (0.07) | (0.37) | 1.15 | 2.38 | 0.78 |
| Deferred: State | (0.43) | (1.07) | 0.32 | (0.15) | (0.07) | (0.08) | (0.03) | 0.12 | 0.12 | 0.60 |
| Deferred: Foreign | (0.75) | (0.03) | (0.81) | (1.20) | (0.50) | (0.07) | (0.56) | (0.48) | (0.28) | (1.90) |
| Current- Foreign | 0.17 | 0.05 | 0.20 | 0.41 | 0.03 | 0.30 | 0.25 | 0.19 | 0.09 | (0.19) |
| Benefit from release of valuation allowance | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Benefit from release of valuation allowance: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Benefit from release of valuation allowance: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Extraordinary Income & Accounting Change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Available to Common Shareholders | 4.13 | (23.98) | 27.19 | 18.72 | 31.82 | 32.55 | 30.76 | 38.32 | 20.58 | 11.76 |
| Basic: Income (loss) before cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic: Cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Basic net income per share | 0.29 | (1.69) | 1.93 | 1.30 | 2.18 | 2.22 | 2.06 | 2.61 | 1.46 | 0.89 |
| Diluted: Income (loss) before cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted: Cumulative effect of change in accounting principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted net income per share | 0.28 | (1.69) | 1.89 | 1.27 | 2.11 | 2.15 | 2.01 | 2.51 | 1.39 | 0.82 |
| Basic weighted average common shares outstanding | 14.40 | 14.22 | 14.12 | 14.44 | 14.58 | 14.68 | 14.93 | 14.68 | 14.09 | 13.26 |
| Diluted weighted average common shares outstanding | 14.63 | 14.22 | 14.37 | 14.69 | 15.07 | 15.12 | 15.32 | 15.27 | 14.83 | 14.34 |